Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4655335 | 0.93 | TSHR (0.38) | TSHRTDP1 | |
| SCHEMBL11590426 | 0.82 | TSHR (0.30) | TSHRTDP1 | |
| SCHEMBL6293924 | 0.81 | TSHR (0.36) | TSHRTDP1 | |
| SCHEMBL8583585 | 0.73 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL1986410 | 0.69 | — | — | |
| SCHEMBL4682302 | 0.69 | CYP2D6 (0.32) | — | |
| SCHEMBL11309012 | 0.67 | — | — | |
| SCHEMBL12902998 | 0.67 | — | — | |
| SCHEMBL270702 | 0.67 | — | — | |
| SCHEMBL72671 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230390277-A1 | METHODS TO SENSITIZE TUMORS TO TREATMENT BY IMMUNOTHERAPY | OHIO STATE INNOVATION FOUNDATION | 2023-12-07 | — | — | US | disclosed |
| EP-2754638-B1 | FILM-FORMING MATERIAL, GROUP IV METAL OXIDE FILM AND VINYLENE DIAMIDE COMPLEX | TOSOH CORP (JP) | 2018-11-07 | — | — | EP | disclosed |
| CN-105001254-B | The manufacturing method of film material, IV family metal oxide films | 东曹株式会社 | 2018-09-11 | — | — | CN | disclosed |
| EP-2939996-B1 | GROUP 5 METAL OXO-ALKOXO COMPLEX, METHOD FOR PRODUCING SAME, AND METHOD FOR MANUFACTURING GROUP 5 METAL OXIDE FILM | TOSOH CORP (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-9663541-B2 | Group 5 metal oxo-alkoxo complex, method for producing same, and method for manufacturing group 5 metal oxide film | TOSOH CORPORATION (JP) | 2017-05-30 | — | — | US | disclosed |
| CN-104884417-B | Group 5 metal oxo-alkoxycomplex, method for producing same, and method for producing group 5 metal oxide film | 东曹株式会社 | 2017-03-15 | — | — | CN | disclosed |
| US-9521847-B2 | Synergistic weed control from applications of pyridine carboxylic acid herbicides and synthetic auxin herbicides and/or auxin transport inhibitors | DOW AGROSCIENCES LLC (US) | 2016-12-20 | — | — | US | disclosed |
| US-9371452-B2 | Film-forming material, group IV metal oxide film and vinylenediamide complex | TOSOH CORPORATION (JP) | 2016-06-21 | — | — | US | disclosed |
| US-20160135458-A1 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF PYRIDINE CARBOXYLIC ACID HERBICIDES AND SYNTHETIC AUXIN HERBICIDES AND/OR AUXIN TRANSPORT INHIBITORS | DOW AGROSCIENCES | 2016-05-19 | — | — | US | disclosed |
| EP-3008037-A1 | HYDROXY-ETHYLENE DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | Merck Patent GmbH (DE) | 2016-04-20 | — | — | EP | disclosed |
| EP-2058295-A1 | IMIDE COMPLEX, METHOD FOR PRODUCING THE SAME, METAL-CONTAINING THIN FILM AND METHOD FOR PRODUCING THE SAME | Tosoh Corporation (JP) | 2009-05-13 | — | — | EP | disclosed |
| EP-1716127-A2 | GUANIDINE COMPOUNDS, AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS | Abbott GmbH & Co. KG (DE) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005118545-A1 | GAS-PHASE OXIDATION OF ALKYL-SUBSTITUTED HETEROCYCLIC COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-15 | — | — | WO | disclosed |
| WO-2005082871-A2 | GUANIDINE COMPOUNDS, AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS | ABBOTT GMBH & CO. KG (DE) | 2005-09-09 | — | — | WO | disclosed |
| EP-1549667-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | Karyon OY (FI) | 2005-07-06 | — | — | EP | disclosed |
| US-6875865-B1 | Selected derivatives of K-252a | CEPHALON, INC. (US) | 2005-04-05 | — | — | US | disclosed |
| WO-2004031221-A9 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004031218-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-04-15 | — | — | WO | disclosed |
| WO-2004031220-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-04-15 | — | — | WO | disclosed |
| US-5969182-A | REACTING CALCIUM CYANAMIDE WITH AN ALCOHOL, REACTING THE RESULTING SUBSTITUTED ISOUREA WITH A PRIMARY OR SECONDARY AMINE | BASF AKTIENGESELLSCHAFT (DE) | 1999-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160135458-A1 | SYNERGISTIC WEED CONTROL FROM APPLICATIONS OF PYRIDINE CARBOXYLIC ACID HERBICIDES AND SYNTHETIC AUXIN HERBICIDES AND/OR AUXIN TRANSPORT INHIBITORS | SLC6A19, SLC16A3, SLC1A5 | TSHR 907/4885TDP1 4018/4885 |
| US-20230390277-A1 | METHODS TO SENSITIZE TUMORS TO TREATMENT BY IMMUNOTHERAPY | TXNRD2, PCK2, DLD | TSHR 4276/4885TDP1 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.